1
GETTING PEOPLE BETTER 804.477.1676 www.gpbscientific.com Summary Multi-parameter flow cytometry is increasingly viewed as a powerful tool in research and clinical applications, driving a growing need for improved efficiency in the area of sample preparation. Current sample preparation methods are labor and time intensive and involve substantial cell losses, typically associated with multiple centrifugation steps. These manual time consuming steps typically lose between 10-30% of cells as a function of which step is involved, frequently resulting in >50% cell loss in complex protocols , and sometimes with preferential loss of specific cell types. Our previous work in a silicon device showed that Deterministic Lateral Displacement (DLD) or “bump array” technology is capable of separating particles on the basis of size. Here, we present the reduction to practice of the DLD approach using a single channel high precision plastic microfluidic device. Conclusions Efficient Depletion of RBCs and WBC Recovery Automated Processing of Human Blood Leukocytes by a Plastic Disposable Microfluidic Deterministic Lateral Displacement Device Tony Ward 1 , Alison M. Skelley 1 , Khushroo Gandhi 1 , Zendra Lee 1 , Christopher R. Dosier 1 , Myra Koesdjojo 1 , Tanisha Saini 1 , Joseph L. D’Silva 2 , Yu Chen 2 , MinJung Kim 3 , James Moynihan 3 , Xiaochun Chen 3 , Lee Aurich 1 , D. Recktenwald 4 , R.H. Austin 5 , Mike Grisham 1 , Curt I Civin 3 , James C. Sturm 2 1 GPB Scientific LLC, 800 East Leigh St., Richmond, VA 23219, 2 Princeton Institute for the Science and Technology of Materials, Department of Electrical Engineering, Princeton University, Princeton, NJ 08544, 3 Center for Stem Cell Biology & Regenerative Medicine and Greenebaum Cancer Center, Departments of Physiology and Pediatrics, University of Maryland School of Medicine, Baltimore, MD, 21201, 4 Desatoya LLC, P.O Box 13282, Reno, NV 89507 5 Princeton Institute for the Science and Technology of Materials, Department of Physics, Princeton University, Princeton, NJ 08544 #146 B10 Effective Recovery of Viable Cells >6µm To test the ability of the Microchip to discriminate smaller cells of interest from erythrocytes, CMFDA labelled mouse Splenocytes were sized and counted using the Coulter principle (A). Labelled cells (B) were spiked into whole blood at 20,000/mL and processed normally, revealing recovery of spiked cells in the DLD cell product (C-D). Size: 4.3-10.1µm Average 6.1 µm A. B. Independent confirmation of size range using impedance counting FSC/SSC plot of Mouse Splenocytes Cell viability was determined using Propidium Iodide. A fluorescence threshold that contained CD45 APC-Cy7 and reference beads (Black) was used to eliminate potential for dead cells appearing below a typical FSC threshold. Microchip is slightly cleaner because of removal of small debris. Control 6.9% PI +ve Microchip Product 4.8% PI +ve Threshold Propidium Iodide APC-Cy7 DLD recovers all major WBC subsets effectively ~1.4M events ~0.4M events ~40K events DLD Microchip Device Time-lapse image showing WBC moving along the tilt angle toward Bypass channel. (blue arrow) Laminar flow of sample through the device results in RBCs flowing directly to waste (red arrow)” Processing via DLD involves pumping 1:1 diluted blood through a specially designed array of microposts under laminar flow conditions in a microscope slide sized chip. The design has a critical dimension of 4.5µm to separate and recover WBCs. Sample enters at the outside edge(s) of the array and cells above a target size are gently deflected by the microposts into a clean stream of running buffer (i.e. washed) in a process that is non-injurious to the cells. Ports collect the product and waste respectively. Single channel schematic shown. SEM of plastic DLD microchip. microposts have >5:1 Aspect ratio & minimal taper Superior WBC Recovery vs Lysis & Ficoll Whole blood from 3 normal donors were red cell depleted via ammonium chloride Lysis, Ficoll, or 14 channel DLD Microchip to assess cell processing losses (2.0 mL per protocol). Lysis protocols were performed with 1 or 2 wash steps to accommodate manufacturer’s protocol variation. Triplicate determinations of WBC and PBMC counts were determined by flow cytometry using a nucleic acid dye (DRAQ5) and absolute count reference particles (eBioscience). Input WBC counts from whole blood were obtained using a 1:400 dilution and a fluorescence threshold that included both reference particles and nucleated cells in ~1:2 ratio. Light scatter and CD45 gating were used to determine PBMC content of cell inputs. DLD Microchip WBC recovery was >99% compared to Lysis using standard protocols which can lose in excess of 35% in a 1 wash protocol and >50% in a 2 wash protocol. Even when a conservative aspiration to include all possible PBMC cells was used, a standard Ficoll protocol lost almost 50% of input PBMCs. The input PBMC portion of the bloods in this study ranged from 18-41%, spanning typical values. Selected References 1. Huang, LR, et al. Science 304: 987-990 (2004) 2. Davis, JA, et al. PNAS USA 103: 14779-14784 (2006) 3. Civin, CI., et al. Submitted RBC Depletion rates of 99.985% combined with efficient and unbiased recovery of WBCs with minimal hands on time has been demonstrated with plastic DLD microchips. Their performance has significantly exceeded the level achieved by current approaches. Microchip processed blood was compared to lysed no wash processing and diluted whole blood control. Cells were stained with CD3/CD19/ CD45 after processing. 8µM DRAQ5 and 123count reference beads (eBioscience) were added to normalize analyzed volumes in microchip product and lysed controls. Data was collected using a forward scatter threshold to allow erythrocyte contamination in the traditional gating region. Column I shows traditional scatter profiles, Column II shows RBC:WBC to bead relative percentages, column III shows light scatter following a DNA gate, and column IV shows traditional lymphocyte subset analysis. The waste fraction shows essentially zero WBC, and the product shows recovery of major subsets with comparable staining and a 5 fold better WBC:RBC ratio versus the Lyse no wash protocol. Initial protocols used a bolus of air to evacuate the microchip at the end of a run (Air Push) and achieved >99% depletion of RBC. On inspection, we found that a small dead volume upstream of microchip in fluidic connectors was impacting RBC depletion rates. A second series, addressing dead volume, was run to evaluate the true performance of the DLD (Buffer Push). This resulted in ~10 fold improvement, achieving 99.985% average RBC depletion In single channel devices an average RBC depletion of 99.985% resulting in WBC:RBC ratios >10:1 was achieved in ~30% less time than a conventional 1 wash lysis procedure and required no hands on steps. Further the DLD cell product stream can be fed directly to a flow cytometer without further processing. DLD was functioning as predicted to recover viable cells 6µm and greater in size. Lysis 2 wash, 42.0% Lysis 1 wash, 59.9% DLD, 99.5% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% % Recovery Total Nucleated Cells Ficoll, 48.3% DLD, 99.6% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% % Recovery PBMC Counts Commercially viable high performance plastic consumable Scalable design offers significant simplification of workflows Does not adversely affect cell viability Superior performance Optimal approach for rare cell enrichment and analysis These results indicate significant user benefits, and suggest their utility for multiple other applications. C. Mouse Human D. DLD product showing Mouse splenocyte recovery Panel C viewed as a histogram Average data Coulter Counter* Flow Cytometer %WBC Recovery % Gran % Mono % Lymph % B Cell % T Cell Time Input* 68.15 5.57 26.30 16.67 74.50 Product 99.32 ND 101.67 68.73 5.50 25.78 16.00 74.95 15.58 Difference 0.58 (0.07) (0.52) (0.67) 0.45 Std.Dev. 0.25 3.81 0.67 0.57 0.98 1.29 1.09 3.91 Std Error 0.10 1.56 0.27 0.23 0.40 0.53 0.44 1.59 Input 53.02 8.03 38.18 10.93 74.88 Product 99.86 99.985 87.78 53.70 9.83 35.97 11.93 74.42 18.33 Difference 0.68 1.80 (2.22) 1.00 (0.47) Std. Dev. 0.21 0.014 7.69 3.18 3.88 3.44 1.18 2.73 1.86 Std Error 0.09 0.006 3.14 1.30 1.59 1.40 0.48 1.11 0.76 WBC Metrics Air Push Buffer Push % RBC Depletion ~70K events n=6 for each Expt. *Donor RBC ranged rom 3.7-4.3e9/mL and WBC ranged from 4.6-9.2e6/mL. Flow RBC depletion data represents the region analyzed within the scatter profile shown in columns I, II above.

Automated Processing of Human Blood Leukocytes by a

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Automated Processing of Human Blood Leukocytes by a

GETTING PEOPLE BETTER 804.477.1676 www.gpbscientific.com

SummaryMulti-parameter flow cytometry is increasingly viewed as a powerful tool in research and clinical applications, driving a growing need for improved efficiency in the area of sample preparation. Current sample preparation methods are labor and time intensive and involve substantial cell losses, typically associated with multiple centrifugation steps. These manual time consuming steps typically lose between 10-30% of cells as a function of which step is involved, frequently resulting in >50% cell loss in complex protocols, and sometimes with preferential loss of specific cell types.

Our previous work in a silicon device showed that Deterministic Lateral Displacement (DLD) or “bump array” technology is capable of separating particles on the basis of size.

Here, we present the reduction to practice of the DLD approach using a single channel high precision plastic microfluidic device.

Conclusions

Efficient Depletion of RBCs and WBC Recovery

Automated Processing of Human Blood Leukocytes by a PlasticDisposable Microfluidic Deterministic Lateral Displacement DeviceTony Ward1, Alison M. Skelley1, Khushroo Gandhi1, Zendra Lee1, Christopher R. Dosier1, Myra Koesdjojo1, Tanisha Saini1, Joseph L. D’Silva2, Yu Chen2, MinJung Kim3, James Moynihan3, Xiaochun Chen3, Lee Aurich1, D. Recktenwald4, R.H. Austin5, Mike Grisham1, Curt I Civin 3, James C. Sturm2

1 GPB Scientific LLC, 800 East Leigh St., Richmond, VA 23219, 2 Princeton Institute for the Science and Technology of Materials, Department of Electrical Engineering, Princeton University, Princeton, NJ 08544, 3 Center for Stem Cell Biology & Regenerative Medicine and Greenebaum Cancer Center, Departments of Physiology and Pediatrics, University of Maryland School of Medicine, Baltimore, MD, 21201, 4 Desatoya LLC, P.O Box 13282, Reno, NV 89507 5 Princeton Institute for the Science and Technology of Materials, Department of Physics, Princeton University, Princeton, NJ 08544

#146B10

Effective Recovery of Viable Cells >6µmTo test the ability of the Microchip to discriminate smaller cells of interest from erythrocytes, CMFDA labelled mouse Splenocytes were sized and counted using the Coulter principle (A). Labelled cells (B) were spiked into whole blood at 20,000/mL and processed normally, revealing recovery of spiked cells in the DLD cell product (C-D).

Size: 4.3-10.1µmAverage 6.1 µmA. B.

Independent confirmation of size range using impedance counting

FSC/SSC plot of Mouse Splenocytes

Cell viability was determined using Propidium Iodide. A fluorescence threshold that contained CD45 APC-Cy7 and reference beads (Black) was used to eliminate potential for dead cells appearing below a typical FSC threshold. Microchip is slightly cleaner because of removal of small debris.

Control6.9% PI +ve

Microchip Product4.8% PI +ve

Threshold

Propidium IodideAPC-Cy7

DLD recovers all major WBC subsets effectively~1.4M events

~0.4M events

~40K events

DLD Microchip Device

Time-lapse image showing WBC moving along the tilt angle toward Bypass channel. (blue arrow)

Laminar flow of sample through the device results in RBCs flowing directly to waste (red arrow)”

Processing via DLD involves pumping 1:1 diluted blood through a specially designed array of microposts under laminar flow conditions in a microscope slide sized chip. The design has a critical dimension of 4.5µm to separate and recover WBCs. Sample enters at the outside edge(s) of the array and cells above a target size are gently deflected by the microposts into a clean stream of running buffer (i.e. washed) in a process that is non-injurious to the cells. Ports collect the product and waste respectively. Single channel schematic shown.

SEM of plastic DLD microchip.microposts have >5:1 Aspect ratio

& minimal taper

Superior WBC Recovery vs Lysis & FicollWhole blood from 3 normal donors were red cell depleted via ammonium chloride Lysis, Ficoll, or 14 channel DLD Microchip to assess cell processing losses (2.0 mL per protocol). Lysis protocols were performed with 1 or 2 wash steps to accommodate manufacturer’s protocol variation. Triplicate determinations of WBC and PBMC counts were determined by flow cytometry using a nucleic acid dye (DRAQ5) and absolute count reference particles (eBioscience).

Input WBC counts from whole blood were obtained using a 1:400 dilution and a fluorescence threshold that included both reference particles and nucleated cells in ~1:2 ratio. Light scatter and CD45 gating were used to determine PBMC content of cell inputs.

DLD Microchip WBC recovery was >99% compared to Lysis using standard protocols which can lose in excess of 35% in a 1 wash protocol and >50% in a 2 wash protocol.

Even when a conservative aspiration to include all possible PBMC cells was used, a standard Ficoll protocol lost almost 50% of input PBMCs. The input PBMC portion of the bloods in this study ranged from 18-41%, spanning typical values.

Selected References1. Huang, LR, et al. Science 304: 987-990 (2004) 2. Davis, JA, et al. PNAS USA 103: 14779-14784 (2006)3. Civin, CI., et al. Submitted

RBC Depletion rates of 99.985% combined with efficient and unbiased recovery of WBCs with minimal hands on time has been demonstrated with plastic DLD microchips. Their performance has significantly exceeded the level achieved by current approaches.

Microchip processed blood was compared to lysed no wash processing and diluted whole blood control.

Cells were stained with CD3/CD19/ CD45 after processing. 8µM DRAQ5 and 123count reference beads (eBioscience) were added to normalize analyzed volumes in microchip product and lysed controls. Data was collected using a forward scatter threshold to allow erythrocyte contamination in the traditional gating region.

Column I shows traditional scatter profiles, Column II shows RBC:WBC to bead relative percentages, column III shows light scatter following a DNA gate, and column IV shows traditional lymphocyte subset analysis.

The waste fraction shows essentially zero WBC, and the product shows recovery of major subsets with comparable staining and a 5 fold better WBC:RBC ratio versus the Lyse no wash protocol.

Initial protocols used a bolus of air to evacuate the microchip at the end of a run (Air Push) and achieved >99% depletion of RBC. On inspection, we found that a small dead volume upstream of microchip in fluidic connectors was impacting RBC depletion rates.

A second series, addressing dead volume, was run to evaluate the true performance of the DLD (Buffer Push). This resulted in ~10 fold improvement, achieving 99.985% average RBC depletion

In single channel devices an average RBC depletion of 99.985% resulting in WBC:RBC ratios >10:1 was achieved in ~30% less time than a conventional 1 wash lysis procedure and required no hands on steps.

Further the DLD cell product stream can be fed directly to a flow cytometer without further processing.

DLD was functioning as predicted to recover viable cells 6µm and greater in size.

Lysis 2 wash, 42.0%

Lysis 1 wash, 59.9%

DLD, 99.5%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

% R

ecov

ery

Total Nucleated Cells

Ficoll, 48.3%

DLD, 99.6%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

% R

ecov

ery

PBMC Counts

• Commercially viable high performance plastic consumable

• Scalable design offers significant simplification of workflows

• Does not adversely affect cell viability• Superior performance• Optimal approach for rare cell enrichment

and analysisThese results indicate significant user benefits, and suggest their utility for multiple other applications.

C.MouseHuman

D.

DLD product showingMouse splenocyte recovery

Panel C viewed as a histogram

Average data

Coulter Counter*

Flow Cytometer

%WBC Recovery % Gran % Mono % Lymph % B Cell % T Cell Time

Input* 68.15 5.57 26.30 16.67 74.50 Product 99.32 ND 101.67 68.73 5.50 25.78 16.00 74.95 15.58 Difference 0.58 (0.07) (0.52) (0.67) 0.45

Std.Dev. 0.25 3.81 0.67 0.57 0.98 1.29 1.09 3.91 Std Error 0.10 1.56 0.27 0.23 0.40 0.53 0.44 1.59

Input 53.02 8.03 38.18 10.93 74.88 Product 99.86 99.985 87.78 53.70 9.83 35.97 11.93 74.42 18.33 Difference 0.68 1.80 (2.22) 1.00 (0.47)

Std. Dev. 0.21 0.014 7.69 3.18 3.88 3.44 1.18 2.73 1.86 Std Error 0.09 0.006 3.14 1.30 1.59 1.40 0.48 1.11 0.76

WBC Metrics

Air

Pus

hB

uffe

r Pus

h

% RBC Depletion

~70K events

n=6 for each Expt. *Donor RBC ranged rom 3.7-4.3e9/mL and WBC ranged from 4.6-9.2e6/mL. Flow RBC depletion data represents the region analyzed within the scatter profile shown in columns I, II above.